GlaxoSmithKline PLC

Pharmaceuticals
United Kingdom
Executive 1Sir Andrew Witty, Chief Executive Officer; | Chief Executive Officer;
Executive 2Ms. Deirdre P. Connelly, President; | Executive Vice President; Chief Financial Officer
Earnings Per Share Growth (%)-48.69%
Cost of Goods Sold (US$ Millions)$11,431
Current Liabilities (US$ Millions)$20,754
Total Assets (US$ Millions)$22,913
Long Term Debt (Millions)$24,728
Return on Equity40.46%
Revenue (US$ Millions)$35,304
Total Company Assets$63,457
Revenue Growth (%)-19.27%
Net Income (US$ Millions)$4,419
Earnings Per Share (US$)$0.89
Total Equity (US$ Millions)$6,655
Profit Margin (%)12.52%
Debt To Equity Ratio (%)3.72%
Inventories (Millions)$6,605